Aerovate Therapeutics, Inc.
Aerovate Therapeutics, Inc. (AVTE) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 356 transactions totaling $90.3M, demonstrating a bullish sentiment with $54.8M in net insider flow. The most recent transaction on Aug 1, 2024 involved a transaction of 1,507 shares valued at $2.6K.
AVTE Insider Activity Summary
Who Is Buying AVTE Stock?
No significant insider buying has been recorded for AVTE in the recent period.
Who Is Selling AVTE Stock?
No significant insider selling has been recorded for AVTE in the recent period.
Is Aerovate Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for AVTE is bullish with an Insider Alignment Score of 80/100 and a net flow of $54.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
AVTE Frequently Asked Questions
Understanding AVTE Insider Activity
Insider trading at Aerovate Therapeutics, Inc. (AVTE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading AVTE stock, having executed 356 transactions in the past 90 days. The most active insider is Rajeev M. Shah (Executive), who has made 5 transactions totaling $40.5M.
Related Tools
Track Aerovate Therapeutics, Inc. Insider Activity
Get notified when executives and directors at AVTE file new Form 4 transactions